A good number of organizations rushing to deploy AI in pharmaceutical and genomics research have their priorities backward. They need not only a solid data infrastructure but also true data savviness before forging ahead with deep learning or large language models, argues Stavros Papadopoulos, CEO and founder of TileDB, the developer of data platform for…